And how serious is this outbreak now? Just give us some context.

Jeremy, good to be back on the show.

So Jeremy, in the DRC, especially that northeastern part of the DRC, that's North Kivu, South Kivu, Ituri Province, it's serious.

I don't think we've seen the peak of this particular outbreak.

Um, and as I'm looking at the numbers, there's already one thousand three hundred and seven confirmed cases in that part of the DRC with three hundred and seventy-seven deaths.

Good news is there are people recovering.

There's a hundred and eighty people recovering.

Uh, Chris, has this outbreak been harder to control than previous ones? For instance, have there been gaps in surveillance and tracing?

How should we understand financing around malaria in trying to gauge the impact that this will have or has had?

Excellent question.

So the financing is always important.

Money is an important thing, and it's a powerful thing, but it's not the only thing, right? And what I feel optimistic about is the following.

So, one, the, within South-- within the African continent and the African CDC and CELAC, the initiatives that are underway, and in fact, many of the African countries that have now incorporated these new and effective malaria vaccines into childhood vaccination schedules, that's smart, and that's using money very wisely and in the right way.

And the other aspects of this too are using the tools we already have.

And what I would like to emphasize is the work that we do and I've been doing daily for ten years, is working with companies, mid-sized to large-sized companies in these countries and looking at, okay, so let's say you have a mine sitting here in the DRC.

Mm.